Pierre Vermette
Fortuna: 31 707 $ al 30/06/2026
Fortuna: 31 707 $ al 30/06/2026
Pierre Vermette currently works at Quest PharmaTech, Inc., as Chief Financial Officer.
Mr. Vermette also formerly worked at Ernst & Young LLP, as Staff Accountant and Mackay & Partners, as Staff Accountant.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
QUEST PHARMATECH INC. 1,04 % | 26/08/2025 | 1.761.518 ( 1,04 % ) | 31 707 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| QUEST PHARMATECH INC. | Director Financiero/CFO | 01/01/2005 |
| Empresas | Cargo | Fin |
|---|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Mackay & Partners
Mackay & Partners Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Quest PharmaTech, Inc.
Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Mackay & Partners
Mackay & Partners Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.